On June 25, 2026, German health ministries published updated guidelines regarding the import of advanced oncology therapies under BfArM frameworks. Given the rapid evolution of targeted therapies, importing specialty drugs like Keytruda or Herceptin has become an essential practice for oncology clinics treating complex cases.

At Critical Kare Pharma, we ensure complete compliance with BfArM and EU regulations. Providing full batch traceability, Certificate of Analysis (COA) records, and strict temperature logs helps German clinical teams offer advanced oncology care with complete safety.

Regulatory & Logistics Requirements in Germany

• BfArM Imports: German regulations allow importation of approved medicines under specific conditions, requiring a valid prescription and documented medical necessity.
• Traceable Quality Control: Every batch is accompanied by documentation that validates source authenticity and chemical stability.
• Validated Cold-Chain: Shipping biologics to German cities like Berlin, Munich, or Frankfurt requires robust insulation to maintain the 2–8°C window across long transit durations.

Ensuring patient safety requires structural rigour. By maintaining a secure cold chain and handling all customs declarations, Critical Kare Pharma remains a key ally for German oncologists seeking direct access to authentic specialty formulations.